Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):463–468. doi: 10.1016/j.ijrobp.2013.02.009

Fig. 3.

Fig. 3

Efficacy of Genexol-PM as a radiosensitizer in chemoradiation therapy for non-small cell lung cancer cell cell lines in vivo. Mice bearing flank tumor xenografts were administered (via tail-vein intravenous injection) saline, Taxol, or Genexol-PM followed by radiation therapy (XRT). Tumors were irradiated in 5 daily fractions of 3 Gy beginning at 6 hours after chemotherapy injection. Changes in tumor volume were measured and the tumor growth delay curves for mice bearing (A) H460 and (B) A549 tumors were generated.